Navigation Links
Hope For Patients With Advanced Breast Cancer

A recent study identified a specific gene that’s responsible for controlling the activated leukocyte cell adhesion molecule ( ALCAM ), which plays a role in helping // cells stay clumped together. The gene is less active in aggressive tumors than in normal breast tissue or tumors that don’t result in a spreading of the disease. Researchers speculate less activity on the part of ALCAM allows tumor cells to more easily separate and migrate to other areas of the body, causing cancer to spread.

Researchers believe they have found an “early warning system” for aggressive breast cancers that will allow them to treat more serious tumors with stronger medicines earlier on in the disease process.The gene can be identified using a test that measures its level of activity in tissue. If the gene is found to be less active in tumor tissue, then the woman can undergo chemotherapy earlier in the course of her disease and possibly avoid progression.

Researchers conducted the study by comparing ALCAM activity in frozen samples of 120 tumors and in 32 samples of normal breast tissue. Women who had died of breast cancer had tumors with notably lower levels of ALCAM than those who did not. Lower levels were also seen in tumors from patients whose cancer spread or recurred.

Researchers say their data clearly suggest that decreased ALCAM expression in the primary tumor is of clinical significance in breast cancer and that reduced expression indicates a more aggressive phenotype and poor prognosis.
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... ... SunView Software’s Service Smart Technology has been selected as a finalist for ... year, Pink Elephant recognizes a new product or service developed by an IT services ... opportunity. The award highlights original innovations that were released in 2016, either as a ...
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve TMS ... is opening a new office in San Clemente, California this month. Achieve TMS ... Southern California, successfully treating individuals struggling with major depression. Depression impacts over 15 ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New York’s fastest ... practitioners on the latest breakthroughs in the prevention, diagnosis and treatment of the ... to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD and ...
(Date:1/17/2017)... ... January 17, 2017 , ... Wettstein ... to families and business professionals throughout central Colorado, is joining local nonprofit Aurora ... The Aurora Warms The Night organization is committed to breaking the cycle of ...
(Date:1/17/2017)... ... 2017 , ... Physicians Education Review®, LCC (PER®) announces philanthropist, ... the 34th Annual Miami Breast Cancer Conference®, on March 9-12, 2017 at the ... said, “We are delighted to have Sandra Lee join us as our keynote ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017  EMD Serono, the biopharmaceutical business ... in the U.S. and Canada , ... joined the company as Senior Vice President and Head ... Smith will oversee the Fertility and Endocrinology businesses in ... launched its first product last year with Gidget™, a ...
(Date:1/17/2017)... PARSIPPANY, N.J. , Jan. 17, 2017 Interpace ... that provides clinically useful molecular diagnostic tests and pathology ... it has received a letter dated January 13, 2017 ... it has regained compliance with the requirement of the ... price of $1.00 per share. The letter ...
(Date:1/17/2017)... , Jan. 17, 2017 Tempus, a ... care, and University Hospitals Seidman Cancer Center have ... making genomic data, advanced molecular analysis and clinical ... physicians and healthcare providers. As ... genomic and transcriptomic sequencing and analysis for ovarian ...
Breaking Medicine Technology: